Overview

About this study

Inflammatory dermatoses are sometimes difficult to diagnose with accuracy using current methods (clinical examination and routine skin biopsy). Targeted therapies (biologics) are available for severe inflammatory dermatoses, but selection of which particular biologic agent to use is often arbitrary. Trials of these medications are expensive and may be multiple before an effective treatment is found.
We propose to develop tissue-based biomarker assays for the diagnosis and therapeutic prognosis for inflammatory skin diseases.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information